203 related articles for article (PubMed ID: 27160112)
1. Myoma migration: an unexpected "effect" with Ulipristal acetate treatment.
Willame A; Marci R; Petignat P; Dubuisson J
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1439-44. PubMed ID: 27160112
[TBL] [Abstract][Full Text] [Related]
2. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
Ferrero S; Alessandri F; Vellone VG; Venturini PL; Leone Roberti Maggiore U
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():43-7. PubMed ID: 27566221
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy.
Ferrero S; Scala C; Vellone VG; Paudice M; Vitale SG; Cianci A; Barra F
Gynecol Obstet Invest; 2020; 85(2):178-183. PubMed ID: 31940645
[TBL] [Abstract][Full Text] [Related]
4. In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment.
Courtoy GE; Donnez J; Marbaix E; Dolmans MM
Fertil Steril; 2015 Aug; 104(2):426-34.e1. PubMed ID: 26003270
[TBL] [Abstract][Full Text] [Related]
5. Does Ulipristal Acetate Affect Surgical Experience at Laparoscopic Myomectomy?
Luketic L; Shirreff L; Kives S; Liu G; El Sugy R; Leyland N; Solnik MJ; Murji A
J Minim Invasive Gynecol; 2017; 24(5):797-802. PubMed ID: 28351762
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter Study Evaluating the Effect of Ulipristal Acetate during Myomectomy.
Murji A; Wais M; Lee S; Pham A; Tai M; Liu G
J Minim Invasive Gynecol; 2018; 25(3):514-521. PubMed ID: 29079463
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment.
Courtoy GE; Henriet P; Marbaix E; de Codt M; Luyckx M; Donnez J; Dolmans MM
J Clin Endocrinol Metab; 2018 Apr; 103(4):1566-1573. PubMed ID: 29408988
[TBL] [Abstract][Full Text] [Related]
8. What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate?
Pourcelot AG; Capmas P; Laberge P; Fernandez H
J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101688. PubMed ID: 31972353
[TBL] [Abstract][Full Text] [Related]
9. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
10. Ulipristal Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study.
Ferrero S; Racca A; Tafi E; Alessandri F; Venturini PL; Leone Roberti Maggiore U
J Minim Invasive Gynecol; 2016; 23(3):390-5. PubMed ID: 26707918
[TBL] [Abstract][Full Text] [Related]
11. First Impressions Can Be Deceiving: Surgical Outcomes of Laparoscopic Myomectomy in Patients Pretreated with Ulipristal Acetate.
Frascà C; Arena A; Degli Esposti E; Raimondo D; Del Forno S; Moro E; Zanello M; Mabrouk M; Seracchioli R
J Minim Invasive Gynecol; 2020; 27(3):633-638. PubMed ID: 31419494
[TBL] [Abstract][Full Text] [Related]
12. Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance?
Ferrero S; Vellone VG; Barra F; Scala C
Gynecol Obstet Invest; 2019; 84(4):313-325. PubMed ID: 30554215
[TBL] [Abstract][Full Text] [Related]
13. Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
Modaffari P; D'alonzo M; Garbagnati M; Pecchio S; Menato G; Biglia N
Gynecol Endocrinol; 2018 Mar; 34(3):192-194. PubMed ID: 28933575
[TBL] [Abstract][Full Text] [Related]
14. Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids.
Szydłowska I; Marciniak A; Nawrocka-Rutkowska J; Rył A; Starczewski A
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32012826
[No Abstract] [Full Text] [Related]
15. Efficacy of ulipristal acetate (UPA) for the treatment of expulsion uterine myomas: report of two cases.
Palaia I; Del Negro V; Fracassi A; Schiavi M; Di Donato V; Fischetti M; Muzii L; Benedetti Panici P
Gynecol Endocrinol; 2020 Jul; 36(7):660-661. PubMed ID: 31878806
[TBL] [Abstract][Full Text] [Related]
16. Ulipristal Acetate Before Hysteroscopic Myomectomy: A Systematic Review.
Vitale SG; Ferrero S; Caruso S; Barra F; Marín-Buck A; Vilos GA; Vitagliano A; Török P; Ciebiera M; Cianci A
Obstet Gynecol Surv; 2020 Feb; 75(2):127-135. PubMed ID: 32105337
[TBL] [Abstract][Full Text] [Related]
17. Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study.
De Franciscis P; Schiattarella A; Riemma G; Labriola D; Ambrosio D; Vitale SG; Cianci A; Cucinella G; Calagna G; Colacurci N
Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):435-440. PubMed ID: 33043778
[TBL] [Abstract][Full Text] [Related]
18. [The molecular mechanisms and morphological manifestations of leiomyoma reduction induced by selective progesterone receptor modulators].
Demura TA; Revazova ZV; Kogan EA; Adamyan LV
Arkh Patol; 2017; 79(3):19-26. PubMed ID: 28631712
[TBL] [Abstract][Full Text] [Related]
19. Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
Istre O
J Minim Invasive Gynecol; 2017 Feb; 24(2):198. PubMed ID: 27539216
[TBL] [Abstract][Full Text] [Related]
20. Ulipristal acetate prior to in vitro fertilization in a female patient affected by uterine fibroids: a case report.
Lo Monte G; Piva I; Graziano A; Engl B; Marci R
Eur Rev Med Pharmacol Sci; 2016; 20(2):202-7. PubMed ID: 26875885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
